6 assets in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Therapeutic assets addressing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Tongji Hospital	P1	CCC (50)
Fludarabine Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Tongji Hospital	P1	CCC (50)
Lcar-Aio T Cells Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1	CC (43)
Universal Cd19 Car-Γδt Cell Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Tongji Hospital	P1	CC (43)
ct103a cells Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Tongji Hospital	Early P1	C (39)
Calculus Bovis Sativus Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease	Tongji Hospital	N/A	NR ()